Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia

Journal of Experimental Medicine

Volumn 212, Issue 6, 2015, Pages 833-843.pdf

  Mansouri, Larry ^a   Sutton, Lesley Ann ^a   Ljungström, Viktor ^a   Bondza, Sina ^a   Arngården, Linda ^a   Bhoi, Sujata ^a   Larsson, Jimmy ^a   Cortese, Diego ^a   Kalushkova, Antonia ^a   Plevova, Karla ^b   Young, Emma ^a   Gunnarsson, Rebeqa ^a   Falk Sörqvist, Elin ^a   Lönn, Peter ^a   Muggen, Alice F ^c   Yan, Xiao Jie ^d   Sander, Birgitta ^e   Enblad, Gunilla ^a   Smedby, Karin E ^f   Juliusson, Gunnar ^g   Belessi, Chrysoula ^h   Rung, Johan ^a   Chiorazzi, Nicholas ^d   Strefford, Jonathan C ⁱ   Langerak, Anton W ^c   Pospisilova, Sarka ^b   Davi, Frederic ^j,k   Hellström, Mats ^a   Jernberg Wiklund, Helena ^a   Ghia, Paolo ^l,m   Söderberg, Ola ^a   Stamatopoulos, Kostas ^a,n   Nilsson, Mats ^a,o   Rosenquist, Richard ^a   more..

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

^g LUND UNIVERSITY   (Sweden)

^h GENERAL HOSPITAL OF NIKEA   (Greece)

ⁱ UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^k CENTRE DE RECHERCHE DES CORDELIERS   (France)

^l SAN RAFFAELE HOSPITAL   (Italy)

^m VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

ⁿ INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^o STOCKHOLM UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; I KAPPA B EPSILON; IBRUTINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKBIE PROTEIN; REGULATOR PROTEIN; SYNAPTOTAGMIN I; TUMOR MARKER; UNCLASSIFIED DRUG; I KAPPA B KINASE; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CLONAL EVOLUTION; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; B CELL LYMPHOMA; CELL NUCLEUS; CELL SURVIVAL; CHROMOSOME ABERRATION; COHORT ANALYSIS; CYTOPLASM; DNA MICROARRAY; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; METABOLISM; PHYSIOLOGY; TREATMENT OUTCOME;

CELL NUCLEUS; CELL SURVIVAL; CHROMOSOME ABERRATIONS; COHORT STUDIES; CYTOPLASM; DNA MUTATIONAL ANALYSIS; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; I-KAPPA B KINASE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, MANTLE-CELL; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84959107133     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20142009     Document Type: Article

References (34)

1. Agathangelidis, A., N. Darzentas, A. Hadzidimitriou, X. Brochet, F. Murray, X.J. Yan, Z. Davis, E.J. van Gastel-Mol, C. Tresoldi, C.C. Chu, et al. 2012. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood. 119:4467-4475. http://dx.doi.org/10.1182/blood-2011-11-393694
2. Alves, B.N., R. Tsui, J. Almaden, M.N. Shokhirev, J. Davis-Turak, J. Fujimoto, H. Birnbaum, J. Ponomarenko, and A. Hoffmann. 2014. IκBε is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner. J. Immunol. 192:3121-3132. http://dx.doi.org/10.4049/jimmunol.1302351
3. Andrews, N.C., and D.V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499. http://dx.doi.org/10.1093/nar/19.9.2499
4. Baliakas, P., A. Hadzidimitriou, L.-A. Sutton, E. Minga, A. Agathangelidis, M. Nichelatti, A. Tsanousa, L. Scarfò, Z. Davis, X.-J. Yan, et al. 2014. Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. The Lancet Haematology. 1:e74-e84. http://dx.doi.org/10.1016/S2352-3026(14)00005-2
5. Baliakas, P., A. Hadzidimitriou, L.A. Sutton, D. Rossi, E. Minga, N. Villamor, M. Larrayoz, J. Kminkova, A. Agathangelidis, Z. Davis, et al. European Research Initiative on CLL (ERIC). 2015. Recurrent mutations refine prognosis in chronic lymphocytic leukemia. Leukemia. 29:329-336. http://dx.doi.org/10.1038/leu.2014.196
6. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc., B. 57:289-300.
7. Bonizzi, G., and M. Karin. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280-288. http://dx.doi.org/10.1016/j.it.2004.03.008
8. Compagno, M., W.K. Lim, A. Grunn, S.V. Nandula, M. Brahmachary, Q. Shen, F. Bertoni, M. Ponzoni, M. Scandurra, A. Califano, et al. 2009. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma. Nature. 459:717-721. http://dx.doi.org/10.1038/nature07968
9. Damm, F., E. Mylonas, A. Cosson, K. Yoshida, V. Della Valle, E. Mouly, M. Diop, L. Scourzic, Y. Shiraishi, K. Chiba, et al. 2014. Acquired initiating mutations in early hematopoietic cells of CLL patients. Cancer Discov. 4:1088-1101. http://dx.doi.org/10.1158/2159-8290.CD-14-0104
10. Davis, R.E., V.N. Ngo, G. Lenz, P. Tolar, R.M. Young, P.B. Romesser, H. Kohlhammer, L. Lamy, H. Zhao, Y. Yang, et al. 2010. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature. 463:88-92. http://dx.doi.org/10.1038/nature08638
11. Emmerich, F., S. Theurich, M. Hummel, A. Haeffker, M.S. Vry, K. Döhner, K. Bommert, H. Stein, and B. Dörken. 2003. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells. J. Pathol. 201:413-420. http://dx.doi.org/10.1002/path.1454
12. Gao, L., J. Ma, K. Mannoor, M.A. Guarnera, A. Shetty, M. Zhan, L. Xing, S.A. Stass, and F. Jiang. 2015. Genome-wide small nucleolar RNA expression analysis of lung cancer by next-generation deep sequencing. Int. J. Cancer. 136:E623-E629. http://dx.doi.org/10.1002/ijc.29169
13. Gunawardana, J., F.C. Chan, A. Telenius, B. Woolcock, R. Kridel, K.L. Tan, S. Ben-Neriah, A. Mottok, R.S. Lim, M. Boyle, et al. 2014. Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma. Nat. Genet. 46:329-335. http://dx.doi.org/10.1038/ng.2900
14. Hallek, M., B.D. Cheson, D. Catovsky, F. Caligaris-Cappio, G. Dighiero, H. Döhner, P. Hillmen, M.J. Keating, E. Montserrat, K.R. Rai, and T.J. Kipps. International Workshop on Chronic Lymphocytic Leukemia. 2008. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 111:5446-5456. http://dx.doi.org/10.1182/blood-2007-06-093906
15. Herishanu, Y., P. Pérez-Galán, D. Liu, A. Biancotto, S. Pittaluga, B. Vire, F. Gibellini, N. Njuguna, E. Lee, L. Stennett, et al. 2011. The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood. 117:563-574. http://dx.doi.org/10.1182/blood-2010-05-284984
16. Hömig-Hölzel, C., C. Hojer, J. Rastelli, S. Casola, L.J. Strobl, W. Müller, L. Quintanilla-Martinez, A. Gewies, J. Ruland, K. Rajewsky, and U. Zimber-Strobl. 2008. Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis. J. Exp. Med. 205:1317-1329. http://dx.doi.org/10.1084/jem.20080238
17. Irizarry, R.A., B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U. Scherf, and T.P. Speed. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 4:249-264. http://dx.doi.org/10.1093/biostatistics/4.2.249
18. Klein, U., Y. Tu, G.A. Stolovitzky, M. Mattioli, G. Cattoretti, H. Husson, A. Freedman, G. Inghirami, L. Cro, L. Baldini, et al. 2001. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 194:1625-1638. http://dx.doi.org/10.1084/jem.194.11.1625
19. Martin, M. 2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet Journal. 17:10-12. http://dx.doi.org/10.14806/ej.17.1.200
20. Mathews Griner, L.A., R. Guha, P. Shinn, R.M. Young, J.M. Keller, D. Liu, I.S. Goldlust, A. Yasgar, C. McKnight, M.B. Boxer, et al. 2014. Highthroughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proc. Natl. Acad. Sci. USA. 111:2349-2354. http://dx.doi.org/10.1073/pnas.1311846111
21. Nilsson, J., O. Söderberg, K. Nilsson, and A. Rosén. 2000. Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells. Blood. 95:1420-1426.
22. Rosén, A., C. Uggla, R. Szigeti, B. Kallin, C. Lindqvist, and J. Zeuthen. 1986. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors. Lymphokine Res. 5:185-204.
23. Rosén, A., A.C. Bergh, P. Gogok, C. Evaldsson, A.L. Myhrinder, E. Hellqvist, A. Rasul, M. Björkholm, M. Jansson, L. Mansouri, et al. 2012. Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection. OncoImmunology. 1:18-27. http://dx.doi.org/10.4161/onci.1.1.18400
24. Rosenwald, A., A.A. Alizadeh, G. Widhopf, R. Simon, R.E. Davis, X. Yu, L. Yang, O.K. Pickeral, L.Z. Rassenti, J. Powell, et al. 2001. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J. Exp. Med. 194:1639-1648. http://dx.doi.org/10.1084/jem.194.11.1639
25. Rossi, D., C. Ciardullo, and G. Gaidano. 2013a. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies. Semin. Cancer Biol. 23:422-430. http://dx.doi.org/10.1016/j.semcancer.2013.04.002
26. Rossi, D., V. Spina, R. Bomben, S. Rasi, M. Dal-Bo, A. Bruscaggin, F.M. Rossi, S. Monti, M. Degan, C. Ciardullo, et al. 2013b. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. Blood. 121:4902-4905. http://dx.doi.org/10.1182/blood-2013-02-486209
27. Siemer, D., J. Kurth, S. Lang, G. Lehnerdt, J. Stanelle, and R. Küppers. 2008. EBV transformation overrides gene expression patterns of B cell differentiation stages. Mol. Immunol. 45:3133-3141. http://dx.doi.org/10.1016/j.molimm.2008.03.002
28. Smedby, K.E., H. Hjalgrim, M. Melbye, A. Torrång, K. Rostgaard, L. Munksgaard, J. Adami, M. Hansen, A. Porwit-MacDonald, B.A. Jensen, et al. 2005. Ultraviolet radiation exposure and risk of malignant lymphomas. J. Natl. Cancer Inst. 97:199-209. http://dx.doi.org/10.1093/jnci/dji022
29. Söderberg, O., U. Thunberg, C. Weigelt, I. Christiansen, T.H. Tötterman, M. Carlsson, J. Sällström, and K. Nilsson. 1999. Staphylococcus aureus Cowan strain 1 activation of B-chronic lymphocytic leukaemia cells augments the response to CD40 stimulation. Scand. J. Immunol. 50:363-370. http://dx.doi.org/10.1046/j.1365-3083.1999.00604.x
30. Söderberg, O., M. Gullberg, M. Jarvius, K. Ridderstråle, K.J. Leuchowius, J. Jarvius, K. Wester, P. Hydbring, F. Bahram, L.G. Larsson, and U. Landegren. 2006. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods. 3:995-1000. http://dx.doi.org/10.1038/nmeth947
31. Stamatopoulos, K., C. Belessi, C. Moreno, M. Boudjograh, G. Guida, T. Smilevska, L. Belhoul, S. Stella, N. Stavroyianni, M. Crespo, et al. 2007. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood. 109:259-270. http://dx.doi.org/10.1182/blood-2006-03-012948
32. Staudt, L.M. 2010. Oncogenic activation of NF-κB. Cold Spring Harb. Perspect. Biol. 2:a000109. http://dx.doi.org/10.1101/cshperspect.a000109
33. Strefford, J.C., L.A. Sutton, P. Baliakas, A. Agathangelidis, J. Malcíková, K. Plevova, L. Scarfó, Z. Davis, E. Stalika, D. Cortese, et al. 2013. Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia. 27:2196-2199. http://dx.doi.org/10.1038/leu.2013.98
34. Wang, K., M. Li, and H. Hakonarson. 2010. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38:e164. http://dx.doi.org/10.1093/nar/gkq603